<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to the patient with neutrophilia
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to the patient with neutrophilia
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to the patient with neutrophilia
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Thomas D Coates, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Peter Newburger, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alan G Rosmarin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 05, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutrophilia refers to an increase of peripheral blood neutrophils at least two standard deviations above the mean. For adults, this generally corresponds to &gt;7700 neutrophils/microL (typically seen in patients with &gt;11,000 white blood cells/microL).
        </p>
        <p>
         This topic will present the clinical evaluation of neutrophilia and its causes. Evaluation of patients with lymphocytosis and eosinophilia are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/104124.html" rel="external">
          "Approach to the adult with lymphocytosis or lymphocytopenia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5691.html" rel="external">
          "Approach to the patient with unexplained eosinophilia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3747512213">
         <span class="h1">
          DEFINITIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The normal range (ie, two standard deviations above and below the mean) for the white blood cell (WBC) count in adults is 4400 to 11,000 cells/microL in most clinical laboratories. Approximately 60 to 70 percent of leukocytes in the peripheral blood are mature polymorphonuclear neutrophils (PMN) [
         <a href="#rid1">
          1
         </a>
         ]. Thus, the threshold for neutrophilia in most clinical laboratories is approximately 7700/microL (11,000 WBC/microL x 70 percent).
        </p>
        <p>
         Normal values for WBC in children vary based on age (
         <a class="graphic graphic_table graphicRef105415" href="/z/d/graphic/105415.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Useful definitions include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Absolute neutrophil count
         </strong>
         (ANC) = WBC (cells/microL) x percent (PMNs + bands) ÷ 100 (
         <a class="calc calc_professional" href="/z/d/html/13483.html" rel="external">
          calculator 1
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neutrophilia
         </strong>
         typically corresponds to ANC &gt;7700/microL
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Leukocyte
         </strong>
         refers to any type of WBC, including neutrophils, eosinophils, basophils, monocytes, and lymphocytes. The various types of leukocytes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4435.html" rel="external">
          "Evaluation of the peripheral blood smear", section on 'White blood cells'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Leukocytosis
         </strong>
         refers to elevated WBC (leukocyte) count. Neutrophilia is the most common type of leukocytosis, but leukocytosis may also be due to increased monocytes, eosinophils, basophils, and/or lymphocytes. (See
         <a class="medical medical_review" href="/z/d/html/104124.html" rel="external">
          "Approach to the adult with lymphocytosis or lymphocytopenia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5691.html" rel="external">
          "Approach to the patient with unexplained eosinophilia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Granulocytosis
         </strong>
         is often used interchangeably with neutrophilia, but granulocytosis is a broader term that can also reflect increased eosinophils or basophils.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Left shift
         </strong>
         is an ill-defined term that refers to an increase in the percentage of band forms, generally accompanied by metamyelocytes and myelocytes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Leukemoid reaction
         </strong>
         refers to WBC &gt;50,000/microL from causes other than leukemia, with the majority being mature neutrophils, often accompanied by increased numbers of bands, metamyelocytes, and/or myelocytes. (See
         <a class="local">
          'Leukemoid reaction/hyperleukocytosis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3147379931">
         <span class="h1">
          MECHANISMS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutrophilia may be due to increased bone marrow production and/or demargination of peripheral blood neutrophils.
        </p>
        <p>
         The peripheral white blood cell (WBC) count is only a crude reflection of neutrophil production, since the vast majority of neutrophils are present in the bone marrow. Proliferation of neutrophil precursors, the process of myeloid differentiation, and entry of these cells into the circulation are tightly regulated by cytokines and are dependent on orderly control of gene expression by transcription factors. Neutrophils persist in the peripheral blood for only about 10 hours before they enter peripheral tissues in response to infection/inflammation, or undergo apoptosis. (See
         <a class="medical medical_review" href="/z/d/html/8380.html" rel="external">
          "Regulation of myelopoiesis"
         </a>
         .)
        </p>
        <p>
         Increased production of neutrophils may be autonomous (ie, due to malignant disorders such as myeloproliferative neoplasms) or reactive (ie, in response to infectious or inflammatory processes).
        </p>
        <p>
         Approximately half of circulating neutrophils are reversibly adherent to the endothelium ("marginated"), so processes that increase neutrophil demargination can rapidly elevate the WBC count.
        </p>
        <p class="headingAnchor" id="H183554308">
         <span class="h1">
          CAUSES OF NEUTROPHILIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Causes of neutrophilia (
         <a class="graphic graphic_table graphicRef80503" href="/z/d/graphic/80503.html" rel="external">
          table 2
         </a>
         ) vary according to the patient population and clinical setting. As examples, the causes of neutrophilia in hospitalized patients differ from those of asymptomatic ambulatory patients, and children are more likely than adults to have inherited disorders.
        </p>
        <p>
         The urgency and nature of the clinical evaluation of neutrophilia are described below. (See
         <a class="local">
          'Urgency of evaluation'
         </a>
         below and
         <a class="local">
          'Clinical evaluation'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3272424300">
         <span class="h2">
          Normal variation
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is considerable variability in neutrophil counts in asymptomatic normal populations. Because neutrophilia is defined as at least two standard deviations above the mean, by definition, 2.5 percent of the normal population will be classified as having neutrophilia.
        </p>
        <p>
         Normal variation is particularly relevant in the asymptomatic patient with persistent mild neutrophilia. Serial evaluation may be required to establish the absence of underlying pathology. Examination of the parents' or siblings' blood counts may be of help in these situations [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p>
         As an example, one report described 34 otherwise healthy subjects with total leukocyte counts of 11,000 to 40,000/microL; other components of the complete blood count were normal other than occasional thrombocytosis, and bone marrow examination was normal [
         <a href="#rid2">
          2
         </a>
         ]. No medical problems became apparent after more than 20 years of follow-up.
        </p>
        <p class="headingAnchor" id="H4074435695">
         <span class="h2">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infections are a common cause of neutrophilia in adults and children, in both the inpatient and outpatient settings. Acute infection should be particularly suspected in patients with a total white blood cell (WBC) count &gt;25,000/microL.
        </p>
        <p>
         Based on personal experience, the WBC count may rise as high as 100,000/microL in patients with infection or inflammation, but the leukocytosis usually decreases within days of starting treatment. As long as the WBC count is decreasing in response to therapy, the neutrophilia is likely to be reactive.
        </p>
        <p>
         Neutrophilia with a left shift is commonly seen in association with acute bacterial infections. The blood smear may reveal toxic granulations, Döhle bodies, and cytoplasmic vacuoles in neutrophils (
         <a class="graphic graphic_picture graphicRef70248" href="/z/d/graphic/70248.html" rel="external">
          picture 1
         </a>
         ). Support for the diagnosis may come from clinical evaluation, microbiologic studies, and associated clinical findings (eg, disseminated intravascular coagulation); markers of inflammation (eg, C-reactive protein [CRP], erythrocyte sedimentation rate [ESR]) are typically abnormal, but nonspecific. Neutrophilia in the setting of viral infections may be accompanied by "atypical" lymphocytes. (See
         <a class="medical medical_review" href="/z/d/html/8387.html" rel="external">
          "Approach to the child with lymphocytosis or lymphocytopenia", section on 'Evaluation of the child with lymphocytosis'
         </a>
         .)
        </p>
        <p>
         Certain bacteria (eg, pneumococcus, staphylococcus, clostridial species) may cause particularly high leukocyte counts. Unexplained leukocytosis in hospitalized patients, even without diarrhea, may be a harbinger of
         <em>
          Clostridioides
         </em>
         <em>
          difficile
         </em>
         infection, and usually occurs after 5 to 10 days of antibiotic treatment [
         <a href="#rid4">
          4,5
         </a>
         ].
        </p>
        <p>
         Neutrophilia in children may be associated with certain viral infections (eg, herpes simplex, varicella), various bacterial infections, leptospiral infections, advanced tuberculosis, and mononucleosis (particularly in the child younger than five years).
        </p>
        <p>
         In one study performed in an emergency department, compared with age-matched controls with moderate leukocytosis (WBC 12,000 to 25,000/microL), patients with WBC count &gt;25,000/microL were more likely to have an infectious disease (74 versus 48 percent) and had a higher mortality rate [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2307589968">
         <span class="h2">
          Inflammation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Both acute and chronic inflammatory processes can cause neutrophilia. Examples include juvenile onset rheumatoid arthritis, Kawasaki disease (in which a leukemoid reaction can occur), rheumatoid arthritis in adults, and adult-onset Still's disease [
         <a href="#rid7">
          7
         </a>
         ]. Patients with Crohn's disease, ulcerative colitis, granulomatous infections, bronchiectasis, or chronic hepatitis may develop neutrophilia, especially during disease flares.
        </p>
        <p>
         Sweet syndrome (also called acute febrile neutrophilic dermatosis), is characterized by neutrophilia, fever, and the abrupt appearance of erythematous, painful, cutaneous plaques. Sweet syndrome is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13784.html" rel="external">
          "Sweet syndrome (acute febrile neutrophilic dermatosis): Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
         Establishing the diagnosis of inflammation as the cause of neutrophilia entails evaluation of the clinical context and exclusion of other causes. CRP and ESR are typically elevated, but they are nonspecific measures of inflammation; nevertheless, these tests are particularly helpful in detecting occult inflammation or infection. There are no diagnostic findings on the peripheral blood smear. Rather, microbiologic studies that exclude infections, or cytogenetic and/or molecular tests that exclude malignancies (eg, chronic myeloid leukemia) may be required to indict inflammation as the cause of neutrophilia.
        </p>
        <p>
         One study of 87 patients with noncystic fibrosis bronchiectasis showed that the neutrophil count was the best correlate for active inflammation [
         <a href="#rid8">
          8
         </a>
         ]. In another study of 110 patients at risk for recurrence of Crohn's disease following surgery, preoperative leukocytosis was significantly associated with recurrence [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3275887241">
         <span class="h2">
          Medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many medications may cause neutrophilia. Among the mechanisms by which drugs may cause neutrophilia are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Stimulation of bone marrow myelopoiesis and/or egress into the circulation (eg, myeloid growth factors and other cytokines,
         <a class="drug drug_general" data-topicid="9262" href="/z/d/drug information/9262.html" rel="external">
          all-trans retinoic acid
         </a>
         [ATRA])
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Demargination of neutrophils within the vasculature (eg, catecholamines)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergic/Inflammatory reaction to a medication (many medications)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Release of granulocytes from the bone marrow (glucocorticoids,
         <a class="drug drug_general" data-topicid="9517" href="/z/d/drug information/9517.html" rel="external">
          plerixafor
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         The drugs most commonly associated with neutrophilia (eg, catecholamines, glucocorticoids, myeloid growth factors,
         <a class="drug drug_general" data-topicid="9517" href="/z/d/drug information/9517.html" rel="external">
          plerixafor
         </a>
         ,
         <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">
          lithium
         </a>
         , ATRA) are listed in the table (
         <a class="graphic graphic_table graphicRef80503" href="/z/d/graphic/80503.html" rel="external">
          table 2
         </a>
         ). Any medication can be considered suspect, but other drugs are less commonly associated with neutrophilia. Review of the medication label and/or a literature search may be useful for implicating a medication as the cause of neutrophilia.
        </p>
        <p>
         Determining the relation between the onset of neutrophilia and administration of medications can provide important clinical clues to the causative agent. Resolution of neutrophilia upon withdrawal of a drug may be the most persuasive evidence of that medication as the cause. There are no diagnostic abnormalities on the peripheral blood smear, but allergic-type drug reactions are often accompanied by modest eosinophilia.
        </p>
        <p>
         Neutrophilia may begin within hours of drug administration (eg, from demargination or accelerated bone marrow release) or days or weeks later (eg, allergic reactions, increased proliferation and/or differentiation).
        </p>
        <p class="headingAnchor" id="H1138924034">
         <span class="h2">
          Asplenia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Moderate neutrophilia is often associated with asplenia, whether it is related to surgical splenectomy [
         <a href="#rid10">
          10,11
         </a>
         ], autoinfarction in sickle cell disease [
         <a href="#rid12">
          12
         </a>
         ], or other causes. Asplenia may cause an exaggerated response to infection or inflammation (ie, leukemoid reaction).
        </p>
        <p>
         Neutrophilia caused by asplenia may be associated with thrombocytosis and the presence of Howell-Jolly bodies (
         <a class="graphic graphic_picture graphicRef60588" href="/z/d/graphic/60588.html" rel="external">
          picture 2
         </a>
         ) or nucleated red blood cells.
        </p>
        <p class="headingAnchor" id="H847603909">
         <span class="h2">
          Cigarette smoking
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cigarette smoking is probably the most common cause of mild neutrophilia in adults. The mechanism underlying this phenomenon is unknown, although smoking-related inflammation has been suggested [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         There are no diagnostic findings in the peripheral blood for cigarette smoking as the cause of neutrophilia, and this diagnosis requires assessment of the clinical context and exclusion of other potential causes.
        </p>
        <p>
         It has been estimated that the WBC count in smokers is raised by about 25 percent, with an approximate doubling of the absolute neutrophil count in subjects who smoke two packs per day [
         <a href="#rid14">
          14,15
         </a>
         ]. While the total WBC count may stay elevated for up to five years after cessation of smoking [
         <a href="#rid14">
          14,16
         </a>
         ], other observations have indicated normalization within months to one or two years [
         <a href="#rid17">
          17-19
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2406028044">
         <span class="h2">
          Stress/exercise
         </span>
         <span class="headingEndMark">
          —
         </span>
         A modest elevation in the neutrophil count has been associated with many types of "stress," including exercise, heat stroke, surgery, and seizures.
        </p>
        <p>
         Neutrophilia can occur within minutes of exercise, stress, or epinephrine injection, and this rapid-onset neutrophilia is presumed to be related to demargination [
         <a href="#rid20">
          20-22
         </a>
         ]. In addition, exercise leads to
         <strong>
         </strong>
         redistribution of neutrophils from the lungs (due to mechanical and blood flow-related effects) and more delayed leukocytosis (about five hours post-exercise) due to bone marrow release of leukocytes [
         <a href="#rid21">
          21,23,24
         </a>
         ]. (See
         <a class="local">
          'Mechanisms'
         </a>
         above.)
        </p>
        <p>
         There are no diagnostic findings for stress as the cause of neutrophilia, and establishing the diagnosis depends on a plausible temporal association and exclusion of other causes.
        </p>
        <p class="headingAnchor" id="H1677692823">
         <span class="h2">
          Obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Isolated leukocytosis, without other explanation, may occasionally be observed in patients with obesity (ie, body mass index [BMI] &gt;30) [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1536078151">
         <span class="h2">
          Endocrine and other causes
         </span>
         <span class="headingEndMark">
          —
         </span>
         A variety of endocrine disorders (eg, thyroid storm, hypercortisolism) and pregnancy-associated conditions (eg, eclampsia, post-partum state) have been associated with neutrophilia. The underlying pathophysiology is poorly understood, but glucocorticoid-associated neutrophil mobilization from the bone marrow and catecholamine-associated demargination of neutrophils may contribute.
        </p>
        <p class="headingAnchor" id="H1216850941">
         <span class="h2">
          Myeloproliferative neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Any of the myeloproliferative neoplasms (MPNs) can be associated with neutrophilia.
        </p>
        <p class="headingAnchor" id="H1631137071">
         <span class="h3">
          Chronic myeloid leukemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic myeloid leukemia (CML) typically presents with the entire spectrum of maturing granulocytic cells (eg, bands, metamyelocytes, myelocytes, promyelocytes, blasts) in the peripheral blood, along with thrombocytosis, polycythemia, eosinophilia and/or basophilia, and splenomegaly. The diagnosis is confirmed by detection of the Philadelphia chromosome (ie, t(9;22)) and/or the
         <em>
          BCR-ABL1
         </em>
         fusion gene. The clinical manifestations and diagnosis of CML are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4543.html" rel="external">
          "Clinical manifestations and diagnosis of chronic myeloid leukemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H558834515">
         <span class="h3">
          Juvenile myelomonocytic leukemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Juvenile myelomonocytic leukemia (JMML) is a rare, aggressive myeloproliferative/myelodysplastic disorder of infancy and childhood that is manifest as neutrophilia and infiltration of the peripheral blood, bone marrow, and viscera by abnormal myelomonocytic cells. JMML is almost always associated with mutations of genes within the RAS/MAPK signaling pathway, and its clinical manifestations and diagnosis are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/96034.html" rel="external">
          "Juvenile myelomonocytic leukemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2219766470">
         <span class="h3">
          Other myeloproliferative neoplasms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutrophilia may accompany any of the MPNs, including polycythemia vera, essential thrombocythemia, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia. Additional details regarding the diagnostic criteria and molecular abnormalities are described separately. (See
         <a class="medical medical_review" href="/z/d/html/4517.html" rel="external">
          "Clinical manifestations and diagnosis of polycythemia vera"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4491.html" rel="external">
          "Clinical manifestations, pathogenesis, and diagnosis of essential thrombocythemia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96031.html" rel="external">
          "Chronic myelomonocytic leukemia: Clinical features, evaluation, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4543.html" rel="external">
          "Clinical manifestations and diagnosis of chronic myeloid leukemia", section on 'Chronic neutrophilic leukemia'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H413369075">
         <span class="h2">
          Nonhematologic malignancy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutrophilia may be associated with nonhematologic malignancies, due to bone marrow metastases, nonspecific inflammation, and/or paraneoplastic effects [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Neutrophilia in the setting of cancer is often associated with anemia of chronic disease/inflammation. Bone marrow metastases may manifest a leukoerythroblastic appearance on the peripheral blood smear. These conditions are discussed in greater detail separately. (See
         <a class="local">
          'Peripheral blood smear'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2048557067">
         <span class="h2">
          Genetic/inherited disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         The likelihood of an inherited cause of neutrophilia is greatest in neonates and children, but some hereditary forms of neutrophilia may not be detected until adulthood.
        </p>
        <p>
         Suspicion for inherited neutrophilia should be higher when other family members manifest hematologic or somatic abnormalities, especially in the setting of abnormalities on the peripheral blood smear. A broad-based focused exome panel is the first step in the evaluation of an inherited disorder of leukocytosis [
         <a href="#rid27">
          27,28
         </a>
         ]. Confirming the diagnosis may involve a broad-based exome panel, bone marrow examination, and referral to an investigator/center with expertise in this type of disorder.
        </p>
        <p class="headingAnchor" id="H2158189727">
         <span class="h3">
          Leukocyte adhesion deficiency
         </span>
         <span class="headingEndMark">
          —
         </span>
         Leukocyte adhesion deficiency (LAD) is a rare disorder caused by inherited defects of leukocyte adhesion molecules. Neonates with LAD typically present with persistent, 5- to 20-fold elevation of leukocytes, delayed separation of the umbilical cord, and recurrent infections.
        </p>
        <p>
         Defining LAD as the cause of leukocytosis depends on proper clinical context and molecular testing to distinguish between infants with LAD I (defects of CD18), LAD II (lack of sialyl Lewis X, the ligand for L-selectin), and LAD III. Additional details are presented separately. (See
         <a class="medical medical_review" href="/z/d/html/3918.html" rel="external">
          "Leukocyte-adhesion deficiency"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1711610547">
         <span class="h3">
          Chronic neutrophilic leukemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chronic neutrophilic leukemia (CNL), which has also been called hereditary chronic neutrophilia, is a rare disorder associated with an activating germline mutation in
         <em>
          CSF3R
         </em>
         , the gene that encodes the granulocyte colony-stimulating factor (G-CSF) receptor [
         <a href="#rid29">
          29,30
         </a>
         ]. The mutation leads to chronic neutrophilia by constitutively activating the G-CSF receptor, thereby promoting granulocyte proliferation and differentiation. The marrow is hypercellular with increased mature granulocytes, no dysplasia and &lt;5 percent blasts [
         <a href="#rid31">
          31
         </a>
         ]. One-third of patients have significant splenomegaly, which may be painful. The prevalence of CNL is not well defined. The neutrophil count can be very high, but is typically in the range of 20,000 to 35,000/microL, with otherwise normal blood counts. This suggests that otherwise asymptomatic patients with persistent, moderately elevated neutrophil counts should be evaluated for the mutations of
         <em>
          CSFR3
         </em>
         . Progression to a myelodysplastic syndrome was observed in approximately 20 percent of cases [
         <a href="#rid29">
          29,30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H228583562">
         <span class="h3">
          Down syndrome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants with Down syndrome (trisomy of chromosome 21) may have a transient abnormal myelopoiesis (also called transient myeloproliferative disorder [TMD] of Down syndrome) that resembles congenital acute leukemia or chronic myeloid leukemia [
         <a href="#rid32">
          32
         </a>
         ]. Affected children can also have exaggerated leukemoid responses to stress [
         <a href="#rid33">
          33
         </a>
         ]. The mechanism by which this occurs is unclear. TMD may resolve spontaneously, but evolves into overt acute myeloid leukemia in a subset of patients. (See
         <a class="medical medical_review" href="/z/d/html/16914.html" rel="external">
          "Transient abnormal myelopoiesis (TAM) of Down syndrome (DS)"
         </a>
         .)
        </p>
        <p>
         The diagnosis is established by identification of blasts on the peripheral blood smear; cytogenetic, immunophenotypic, and molecular testing (ie, detection of
         <em>
          GATA1
         </em>
         mutation); and exclusion of acute myeloid leukemia. (See
         <a class="medical medical_review" href="/z/d/html/16914.html" rel="external">
          "Transient abnormal myelopoiesis (TAM) of Down syndrome (DS)", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         Transient leukemoid reactions simulating acute leukemia have also been seen in phenotypically normal children who expressed trisomy 21 mosaicism in myeloid cells but not in skin fibroblasts. The chromosomal abnormalities disappeared after the leukemoid reaction resolved [
         <a href="#rid34">
          34,35
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H339513800">
         <span class="h3">
          Cryopyrin-associated periodic syndromes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cryopyrin-associated periodic syndromes, including familial cold autoinflammatory syndrome (also called familial cold-induced urticaria) and the Muckle-Wells syndrome, are rare inherited conditions with protean clinical manifestations that may include neutrophilia and inflammation of skin, joints, central nervous system, and eyes.
        </p>
        <p>
         There are no defining features on the peripheral blood smear, but these disorders may be diagnosed by detection of mutations in
         <em>
          NLRP3
         </em>
         (the gene encoding cryopyrin). These disorders are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5585.html" rel="external">
          "Cryopyrin-associated periodic syndromes and related disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H732441397">
         <span class="h1">
          URGENCY OF EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The urgency of evaluation of neutrophilia is guided by the patient's clinical condition, the presence of worrisome findings on other blood tests (eg, leukemic blasts, disseminated intravascular coagulation), and the degree and rate of rise of neutrophilia (if known).
        </p>
        <p>
         As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neutrophilia accompanied by clinical instability (eg, hypotension, high fever, hypothermia, abdominal rebound tenderness) usually requires immediate hospitalization and urgent evaluation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asymptomatic, modest neutrophilia may be monitored and evaluated as an outpatient if the patient is clinically stable.
        </p>
        <p>
        </p>
        <p>
         White blood cell count &gt;100,000/microL may warrant urgent hematologic consultation, including consideration of emergency leukapheresis to prevent vaso-occlusive complications of hyperviscosity. Leukemic blast cells, because of their nondeformability, cause hyperviscosity at lower cell counts (approximately 75,000/microL). (See
         <a class="medical medical_review" href="/z/d/html/4522.html" rel="external">
          "Hyperleukocytosis and leukostasis in hematologic malignancies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3160636894">
         <span class="h1">
          CLINICAL EVALUATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutrophilia may be encountered in the course of evaluating other clinical findings or as an incidental abnormality on a complete blood count (CBC). Initial evaluation includes history and physical examination, review of the peripheral blood smear, and other laboratory studies. The abnormal CBC should be repeated in order to exclude laboratory error and other reasons for spurious reports of neutrophilia. The repeated specimen should be evaluated by the clinical laboratory promptly. (See
         <a class="local">
          'Spurious neutrophilia (artifacts)'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          History and physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The history should seek evidence of underlying causes of reactive or malignant disorders that can account for neutrophilia. (See
         <a class="local">
          'Causes of neutrophilia'
         </a>
         above.)
        </p>
        <p>
         When available, a history of previous CBCs (normal and abnormal) can provide crucial information about the duration and trajectory of neutrophilia.
        </p>
        <p>
         Important aspects of the history include evidence of:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Active or prior infection or inflammation (see
         <a class="local">
          'Infection'
         </a>
         above and
         <a class="local">
          'Inflammation'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hematologic malignancies (eg, myeloproliferative neoplasms, acute leukemias) or other hematologic disorders (eg, sickle cell disease) (see
         <a class="local">
          'Myeloproliferative neoplasms'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgical or functional asplenia (see
         <a class="local">
          'Asplenia'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cigarette smoking (see
         <a class="local">
          'Cigarette smoking'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vigorous exercise (see
         <a class="local">
          'Stress/exercise'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extreme physical or emotional distress (see
         <a class="local">
          'Stress/exercise'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Conditions that may be associated with neutrophilia (eg, pregnancy, eclampsia, post-partum, thyroid storm, hypercortisolism)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Family history of neutrophilia (see
         <a class="local">
          'Genetic/inherited disorders'
         </a>
         above)
        </p>
        <p>
        </p>
        <p>
         The physical examination should seek evidence of infection, inflammation, or malignancy, such as fever, lymphadenopathy, hepatosplenomegaly, joint redness, abdominal pain, and pulmonary abnormalities.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Medications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Numerous medications may cause neutrophilia. The relationship between the onset of neutrophilia and administration of various medications should be defined.
        </p>
        <p>
         The most commonly associated drugs are listed in the table (eg, catecholamines, glucocorticoids, myeloid growth factors,
         <a class="drug drug_general" data-topicid="9566" href="/z/d/drug information/9566.html" rel="external">
          lithium
         </a>
         ,
         <a class="drug drug_general" data-topicid="9262" href="/z/d/drug information/9262.html" rel="external">
          all-trans retinoic acid
         </a>
         ) (
         <a class="graphic graphic_table graphicRef80503" href="/z/d/graphic/80503.html" rel="external">
          table 2
         </a>
         ). Other drugs are occasionally reported to be associated with neutrophilia. (See
         <a class="local">
          'Medications'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H210470619">
         <span class="h2">
          Complete blood count (CBC)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The CBC and differential count provide essential information about the number and nature of neutrophils (and immature precursors), other leukocytes, red blood cells (RBCs), and platelets.
        </p>
        <p>
         Neutrophilia may be the sole abnormality on the CBC or it may be accompanied by abnormalities in other lineages. (See
         <a class="local">
          'Neutrophilia combined with other hematologic abnormalities'
         </a>
         below.)
        </p>
        <p>
         Automated particle counters provide a differential count (the percentage of various types of leukocytes, including immature granulocytic forms). In the setting of neutrophilia, the differential count should be confirmed and validated by a review of the peripheral blood smear (below). (See
         <a class="medical medical_review" href="/z/d/html/4430.html" rel="external">
          "Automated complete blood count (CBC)"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3940150846">
         <span class="h2">
          Peripheral blood smear
         </span>
         <span class="headingEndMark">
          —
         </span>
         Review of the peripheral blood smear is important to evaluate the neutrophils, identify abnormalities in other lineages, and exclude spurious leukocytosis. Examination of the peripheral blood smear and findings relevant to the evaluation of neutrophilia are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4435.html" rel="external">
          "Evaluation of the peripheral blood smear"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1947109350">
         <span class="h3">
          Neutrophil abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Examples include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Left shift of granulocytes (ie, abundant band forms, metamyelocytes, myelocytes) may be due to severe infection/sepsis or chronic myeloid leukemia (CML), while the presence of significant number of myeloid blasts suggests acute myeloid leukemia (AML) (
         <a class="graphic graphic_picture graphicRef59431" href="/z/d/graphic/59431.html" rel="external">
          picture 3
         </a>
         ); occasionally, blasts can be seen with extreme inflammation/bone marrow stimulation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Döhle bodies and toxic granulations suggest an infectious or inflammatory process (
         <a class="graphic graphic_picture graphicRef70248" href="/z/d/graphic/70248.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dysplastic leukocytes may be due to chronic myelomonocytic leukemia (CMML) (
         <a class="graphic graphic_picture graphicRef85880" href="/z/d/graphic/85880.html" rel="external">
          picture 4
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4277186735">
         <span class="h3">
          Spurious neutrophilia (artifacts)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Examples of artifacts that may yield falsely elevated (spurious) neutrophilia include:
        </p>
        <p class="headingAnchor" id="H3113305950">
         <span class="h4">
          Platelet clumping
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clumping of platelets can cause spurious neutrophilia in an automated particle counter. Examination of the peripheral smear will reveal platelet clumping. A repeat blood sample adequately anticoagulated with citrate or heparin (rather than EDTA) should resolve this problem.
        </p>
        <p>
         Platelet clumping can occur under the following circumstances:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Insufficient anticoagulation
         </strong>
         – Inadequate anticoagulation may cause platelet aggregation by some automated cell counters. However, the white blood cell (WBC) count is rarely increased by more than 10 percent and there is usually an associated spurious thrombocytopenia [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pseudothrombocytopenia
         </strong>
         – Normal subjects with EDTA-dependent agglutinins may exhibit platelet clumping that can be erroneously reported as leukocytosis (pseudoleukocytosis) (
         <a class="graphic graphic_picture graphicRef68949" href="/z/d/graphic/68949.html" rel="external">
          picture 5
         </a>
         ) [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6680.html" rel="external">
          "Diagnostic approach to thrombocytopenia in adults", section on 'Pseudothrombocytopenia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H632299616">
         <span class="h4">
          Cryoglobulinemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         When cold-insoluble plasma proteins are present, a temperature-dependent increase in leukocyte and platelet counts occurs at temperatures of 30°C or less. This can result in WBC counts as high as 50,000/microL and a doubling of the platelet count, both of which are attributed to various sizes of precipitated cryoglobulin particles [
         <a href="#rid38">
          38
         </a>
         ]. This effect is increased if the sample is allowed to cool to lower temperatures and disappears if the sample is kept at body temperature. A repeat blood sample maintained at body temperature should resolve this problem. (See
         <a class="medical medical_review" href="/z/d/html/1825.html" rel="external">
          "Overview of cryoglobulins and cryoglobulinemia", section on 'Detection of cryoglobulins'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1244063188">
         <span class="h3">
          Neutrophilia combined with other hematologic abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neutrophilia may be an isolated abnormality (the sole abnormality on CBC and/or blood smear) or it may be associated with abnormalities of other leukocytes, RBCs, and/or platelets.
        </p>
        <p>
         Examples of conditions in which neutrophilia is associated with other abnormalities include:
        </p>
        <p class="headingAnchor" id="H3126953843">
         <span class="h4">
          Other leukocyte abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain causes of neutrophilia are more common in patients with elevated levels of monocytes, eosinophils, or basophils. (See
         <a class="medical medical_review" href="/z/d/html/5691.html" rel="external">
          "Approach to the patient with unexplained eosinophilia"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Monocytes
         </strong>
         –
         <strong>
         </strong>
         Monocytosis may accompany neutrophilia in various conditions, including:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infections: brucellosis, varicella-zoster, bacterial endocarditis, tuberculosis, malaria, typhoid fever, syphilis, trypanosomiasis, and others
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Malignancies: CMML, CML, AML, Hodgkin lymphoma
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inflammatory conditions: sarcoidosis, inflammatory bowel disease, other autoimmune conditions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Medications: corticosteroids, myeloid growth factors
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other conditions: pregnancy, asplenia
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Eosinophils or basophils
         </strong>
         – Eosinophilia and or basophilia accompanying neutrophilia may be due to:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Allergic conditions
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infections (eg, helminths, toxocariasis, trichinellosis, protozoal infections, other parasites)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Malignancies (eg, CML, other MPNs, Hodgkin lymphoma, acute eosinophilic leukemia, systemic mastocytosis, others)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inflammatory conditions: sarcoidosis, inflammatory bowel disease
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3065517831">
         <span class="h4">
          Red blood cells (RBCs)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disorders of RBCs are often associated with neutrophilia. Review of RBC indices, the peripheral blood smear, and other laboratory tests may provide important information about underlying causes. (See
         <a class="medical medical_review" href="/z/d/html/4435.html" rel="external">
          "Evaluation of the peripheral blood smear"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7133.html" rel="external">
          "Diagnostic approach to anemia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5927.html" rel="external">
          "Approach to the child with anemia"
         </a>
         .)
        </p>
        <p>
         Examples of RBC abnormalities that may be associated with neutrophilia include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microangiopathic hemolytic anemia (MAHA)
         </strong>
         – MAHA (ie, fragmented RBCs on peripheral blood smear) is suspicious for thrombotic thrombocytopenic purpura (TTP), disseminated intravascular coagulation (DIC), and related disorders, which require urgent evaluation. These are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/88648.html" rel="external">
          "Diagnostic approach to suspected TTP, HUS, or other thrombotic microangiopathy (TMA)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1306.html" rel="external">
          "Evaluation and management of disseminated intravascular coagulation (DIC) in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Leukoerythroblastosis
         </strong>
         – Leukoerythroblastosis (
         <a class="graphic graphic_picture graphicRef68110" href="/z/d/graphic/68110.html" rel="external">
          picture 6
         </a>
         ) is characterized by teardrop-shaped red cells (
         <a class="graphic graphic_picture graphicRef55274" href="/z/d/graphic/55274.html" rel="external">
          picture 7
         </a>
         ), nucleated red cells, and immature WBC forms. Detection of leukoerythroblastosis suggests a myelophthisic process (eg, primary myelofibrosis, other MPNs, cancer metastatic to the bone marrow, and occasionally, vasculitis or fungal or tuberculous infection) (
         <a class="graphic graphic_table graphicRef80503" href="/z/d/graphic/80503.html" rel="external">
          table 2
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Anemia
         </strong>
         – Anemia has numerous causes and is frequently associated with neutrophilia. Anemia is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/7133.html" rel="external">
          "Diagnostic approach to anemia in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5927.html" rel="external">
          "Approach to the child with anemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Polycythemia
         </strong>
         – Polycythemia (elevated hemoglobin and/or hematocrit) suggests an underlying MPN (eg, polycythemia vera, CML, others), especially if accompanied by eosinophilia and/or basophilia. Relative polycythemia due to loss of plasma volume may be seen in sepsis or other infectious conditions. (See
         <a class="medical medical_review" href="/z/d/html/7075.html" rel="external">
          "Diagnostic approach to the patient with erythrocytosis/polycythemia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4517.html" rel="external">
          "Clinical manifestations and diagnosis of polycythemia vera"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1445578991">
         <span class="h4">
          Platelets
         </span>
         <span class="headingEndMark">
          —
         </span>
         Examples of platelet abnormalities that may be associated with neutrophilia include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Thrombocytosis
         </strong>
         – Thrombocytosis accompanying neutrophilia may be due to various infectious, inflammatory, or malignant conditions (eg, MPNs), or following periods of marrow recovery. (See
         <a class="medical medical_review" href="/z/d/html/6682.html" rel="external">
          "Approach to the patient with thrombocytosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4491.html" rel="external">
          "Clinical manifestations, pathogenesis, and diagnosis of essential thrombocythemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Thrombocytopenia
         </strong>
         – Thrombocytopenia associated with neutrophilia may be seen in sepsis from acute bacterial infection, with or without DIC. Associated findings on the peripheral smear are a pronounced left shift and toxic granulations, Döhle bodies, and cytoplasmic vacuoles (
         <a class="graphic graphic_picture graphicRef70248" href="/z/d/graphic/70248.html" rel="external">
          picture 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Thrombocytopenia accompanied by MAHA may represent DIC, TTP, or hemolytic uremic syndrome. (See
         <a class="medical medical_review" href="/z/d/html/89549.html" rel="external">
          "Overview of hemolytic uremic syndrome in children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H835275612">
         <span class="h3">
          Other laboratory tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Examples of testing that may help to distinguish malignant disorders from reactive causes of neutrophilia in the initial evaluation of neutrophilia include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Renal and liver function tests
         </strong>
         should be performed in all patients as they may identify associated medical conditions or complications.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP)
         </strong>
         are elevated in inflammation and infection, and may be helpful in evaluating the cause of neutrophilia in an asymptomatic patient.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Coagulation testing
         </strong>
         may support the diagnosis of neutrophilia associated with sepsis (eg, elevated D-dimer in DIC).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tests for
         </strong>
         <strong>
          <em>
           Clostridioides difficile
          </em>
         </strong>
         may be considered in a hospitalized patient with unexplained leukocytosis after antibiotic treatment, since this disorder has a protean clinical presentation. (See
         <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1864470656">
         <span class="h2">
          Specialized testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Findings from the initial evaluation (history, physical examination, CBC, peripheral blood smear) should permit the clinician to generate a differential diagnosis for neutrophilia. In many cases, serial observation alone may be sufficient when no cause has been identified from the initial clinical evaluation. As an example, an asymptomatic patient with modest, stable neutrophilia might simply be followed as an outpatient with serial CBCs.
        </p>
        <p>
         In some cases, additional testing may be required to confirm the underlying cause of neutrophilia. However, these tests should not be routinely or universally applied; rather, they should be utilized to confirm or exclude particular diagnoses.
        </p>
        <p>
         Examples of specialized testing that may be useful based on findings from the initial evaluation include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bone marrow aspirate and biopsy
         </strong>
         – Bone marrow examination is not required for the evaluation of most cases of neutrophilia. Nevertheless, it may yield critical information based on marrow morphology, flow cytometry, microbiologic testing (eg, stains and/or cultures for fungi and mycobacteria, if warranted), and cytogenetic and molecular analysis. Bone marrow biopsy is essential for confirming the diagnosis in AML and in some other hematologic malignancies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Flow cytometry
         </strong>
         – Immunophenotyping of the peripheral blood may demonstrate clonal disorders, such as CML, polycythemia vera, essential thrombocythemia, and other hematologic malignancies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Molecular/genetic testing
         </strong>
         – In some patients, molecular testing may be required to confirm or exclude a diagnosis. Examples include testing of peripheral blood or bone marrow for
         <em>
          BCR/ABL1
         </em>
         to confirm the diagnosis of CML, or for karyotype and
         <em>
          GATA1
         </em>
         to assess transient abnormal myelopoiesis of Down syndrome.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h1">
          LEUKEMOID REACTION/HYPERLEUKOCYTOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Leukemoid reaction refers to a white blood cell (WBC) count &gt;50,000/microL from causes other than leukemia. The majority of cells are mature neutrophils, often accompanied by a prominent left shift.
        </p>
        <p>
         Examples of conditions that may be associated with leukemoid reactions include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infections:
         <em>
          Clostridioides difficile
         </em>
         , tuberculosis, pertussis, visceral larva migrans (associated with prominent eosinophilia)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Medications: myeloid cytokines,
         <a class="drug drug_general" data-topicid="9262" href="/z/d/drug information/9262.html" rel="external">
          all-trans retinoic acid
         </a>
         (see
         <a class="medical medical_review" href="/z/d/html/4351.html" rel="external">
          "Differentiation syndrome associated with treatment of acute leukemia"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Asplenia/hyposplenia (surgical or functional)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonhematologic malignancies [
         <a href="#rid26">
          26
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         WBC &gt;100,000/microL may warrant urgent hematologic consultation, including consideration of emergency leukapheresis to prevent the vaso-occlusive complications of hyperviscosity. Leukemic blast cells, because of their nondeformability, cause hyperviscosity at lower cell counts (approximately 75,000/microL). (See
         <a class="medical medical_review" href="/z/d/html/4522.html" rel="external">
          "Hyperleukocytosis and leukostasis in hematologic malignancies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9379019">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Distribution of neutrophils
         </strong>
         – Neutrophils, also called polymorphonuclear cells (PMNs), are the most abundant white blood cell (WBC; leukocyte). Neutrophils mature from myeloid progenitor cells in bone marrow and migrate to sites of inflammation throughout the body.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The neutrophil count only roughly corresponds with total quantity of myeloid cells because neutrophils pass briefly through the blood stream and half of circulating PMNs are marginated (reversibly adherent to the vascular endothelium). Increased levels of neutrophils may reflect increased production and/or increased demargination.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Absolute neutrophil count
         </strong>
         <strong>
          (ANC)
         </strong>
         – Calculation: ANC = WBC/microL x percent (PMNs + bands) ÷ 100 (
         <a class="calc calc_professional" href="/z/d/html/13483.html" rel="external">
          calculator 1
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Criteria for neutrophilia vary with age:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Adults
         </strong>
         – ANC &gt;7700 /microL. (See
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Children
         </strong>
         – Normal values for WBC vary with age (
         <a class="graphic graphic_table graphicRef105415" href="/z/d/graphic/105415.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initial evaluation
         </strong>
         – Initial evaluation for neutrophilia includes (see
         <a class="local">
          'Clinical evaluation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical
         </strong>
         – History and physical examination may identify features that suggest specific diagnoses (
         <a class="graphic graphic_table graphicRef80503" href="/z/d/graphic/80503.html" rel="external">
          table 2
         </a>
         ). Examples include evaluation for fever, lymphadenopathy, other findings associated with infection/inflammation, recent surgery, medications, smoking, asplenia, and recent vigorous exercise or extreme stress. Unexplained weight loss, fevers, sweats, or splenomegaly may suggest a myeloproliferative neoplasm (MPN).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Laboratory
         </strong>
         – Helpful information from initial studies include:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Complete blood count (CBC) and differential count
         </strong>
         – What is the ANC, is there a "left-shift" in circulating myeloid cells, and are there abnormalities of red blood cells (RBCs) and platelets?
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Blood smear
         </strong>
         – Are blasts, dysplasia, toxic granulations, microangiopathy (eg, teardrop cells, schistocytes), platelet clumping (ie, spurious neutrophilia), or other abnormal findings present?
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Further evaluation
         </strong>
         – The initial evaluation should generate a differential diagnosis and help determine if further testing is needed.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Lesser concern
         </strong>
         – Observation without immediate further testing is reasonable for clinically stable patients with modest neutrophilia (eg, &lt;20,000/microL) and no worrisome clinical or laboratory findings from the initial evaluation. Possible causes include cigarette smoking, stress/exercise, obesity, and history of splenectomy. (See
         <a class="local">
          'Causes of neutrophilia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Greater concern
         </strong>
         – Further evaluation is needed for worrisome features on blood smear, rising WBC, or concerning clinical or laboratory findings. Examples include:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Infection/inflammation
         </strong>
         – Clinical evaluation, microbiologic studies, left shift of CBC, or toxic granulations (
         <a class="graphic graphic_picture graphicRef70248" href="/z/d/graphic/70248.html" rel="external">
          picture 1
         </a>
         ) suggest an infection or inflammatory condition. Severe infections can cause WBC &gt;20,000/microL and/or disseminated intravascular coagulation (DIC). (See
         <a class="local">
          'Infection'
         </a>
         above and
         <a class="local">
          'Inflammation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Medications
         </strong>
         – Many drugs can cause neutrophilia (
         <a class="graphic graphic_table graphicRef80503" href="/z/d/graphic/80503.html" rel="external">
          table 2
         </a>
         ) due to allergic/inflammatory reactions; such reactions are often accompanied by modest eosinophilia, but no specific tests prove the role of a medication. Glucocorticoids or myeloid growth factors (eg, G-CSF) increase release of neutrophils from bone marrow and catecholamines increase demargination of PMNs. The relation of drug administration with onset of neutrophilia and resolution upon withdrawal provide the most persuasive evidence. (See
         <a class="local">
          'Medications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Suspected hematologic malignancy
         </strong>
         – For patients with unexplained weight loss, fevers, sweats, or splenomegaly; abnormal forms on blood smear (eg, blasts) (
         <a class="graphic graphic_picture graphicRef78291" href="/z/d/graphic/78291.html" rel="external">
          picture 8
         </a>
         ), and abnormalities in other lineages, bone marrow examination should be performed to evaluate the patient for an MPN or other hematologic malignancy. (See
         <a class="local">
          'Myeloproliferative neoplasms'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1350765638">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges extensive contributions of Donald H Mahoney, Jr, MD to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Hollowell JG, van Assendelft OW, Gunter EW, et al. Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94. Vital Health Stat 11 2005; :1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ward HN, Reinhard EH. Chronic idiopathic leukocytosis. Ann Intern Med 1971; 75:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caramihai E, Karayalcin G, Aballi AJ, Lanzkowsky P. Leukocyte count differences in healthy white and black children 1 to 5 years of age. J Pediatr 1975; 86:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wanahita A, Goldsmith EA, Musher DM. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile. Clin Infect Dis 2002; 34:1585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults: a systematic review. JAMA 2015; 313:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawrence YR, Raveh D, Rudensky B, Munter G. Extreme leukocytosis in the emergency department. QJM 2007; 100:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore) 1991; 70:118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson CB, Jones PW, O'Leary CJ, et al. Systemic markers of inflammation in stable bronchiectasis. Eur Respir J 1998; 12:820.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Caprilli R, Corrao G, Taddei G, et al. Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Dis Colon Rectum 1996; 39:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McBride JA, Dacie JV, Shapley R. The effect of splenectomy on the leucocyte count. Br J Haematol 1968; 14:225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spencer RP, McPhedran P, Finch SC, Morgan WS. Persistent neutrophilic leukocytosis associated with idiopathic functional asplenia. J Nucl Med 1972; 13:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 1969; 281:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fröhlich M, Sund M, Löwel H, et al. Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95). Eur Heart J 2003; 24:1365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parry H, Cohen S, Schlarb JE, et al. Smoking, alcohol consumption, and leukocyte counts. Am J Clin Pathol 1997; 107:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz J, Weiss ST. Cigarette smoking and peripheral blood leukocyte differentials. Ann Epidemiol 1994; 4:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawada T. Smoking-induced leukocytosis can persist after cessation of smoking. Arch Med Res 2004; 35:246.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Tiel E, Peeters PH, Smit HA, et al. Quitting smoking may restore hematological characteristics within five years. Ann Epidemiol 2002; 12:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abel GA, Hays JT, Decker PA, et al. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clin Proc 2005; 80:1022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith CJ, Kluck LA, Ruan GJ, et al. Leukocytosis and Tobacco Use: An Observational Study of Asymptomatic Leukocytosis. Am J Med 2021; 134:e31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boxer LA, Allen JM, Baehner RL. Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine. J Clin Invest 1980; 66:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christensen RD, Hill HR. Exercise-induced changes in the blood concentration of leukocyte populations in teenage athletes. Am J Pediatr Hematol Oncol 1987; 9:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christensen RD, Rothstein G. Pitfalls in the interpretation of leukocyte counts of newborn infants. Am J Clin Pathol 1979; 72:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foster NK, Martyn JB, Rangno RE, et al. Leukocytosis of exercise: role of cardiac output and catecholamines. J Appl Physiol (1985) 1986; 61:2218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy DA, Perry JD, Melsom RD, Dale MM. Leucocytosis induced by exercise. Br Med J (Clin Res Ed) 1987; 295:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herishanu Y, Rogowski O, Polliack A, Marilus R. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 2006; 76:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Granger JM, Kontoyiannis DP. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer 2009; 115:3919.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scaramellini N, Croci G, De Magistris C, et al. Splenomegaly: Dare to think rare. Am J Hematol 2022; 97:1259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Montano C, Cassini T, Ziegler SG, et al. Diagnosis and discovery: Insights from the NIH Undiagnosed Diseases Program. J Inherit Metab Dis 2022; 45:907.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duployez N, Willekens C, Plo I, et al. Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia. Blood 2019; 134:2414.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliott MA, Tefferi A. Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management. Am J Hematol 2018; 93:578.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127:2375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinstein HJ. Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome. Clin Haematol 1978; 7:147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubins J, Wakem CJ. Hypoglycemia and leukemoid reaction with hypernephroma. N Y State J Med 1977; 77:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones GR, Weaver M, Laug WE. Transient blastemia in phenotypically normal newborns. Am J Pediatr Hematol Oncol 1987; 9:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brodeur GM, Dahl GV, Williams DL, et al. Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn. Blood 1980; 55:691.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Solanki DL, Blackburn BC. Spurious leukocytosis and thrombocytopenia. A dual phenomenon caused by clumping of platelets in vitro. JAMA 1983; 250:2514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savage RA. Pseudoleukocytosis due to EDTA-induced platelet clumping. Am J Clin Pathol 1984; 81:317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel KJ, Hughes CG, Parapia LA. Pseudoleucocytosis and pseudothrombocytosis due to cryoglobulinaemia. J Clin Pathol 1987; 40:120.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 8381 Version 41.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15782774" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Hematological and iron-related analytes--reference data for persons aged 1 year and over: United States, 1988-94.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5558646" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Chronic idiopathic leukocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1111693" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Leukocyte count differences in healthy white and black children 1 to 5 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12032893" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25626036" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Diagnosis and treatment of Clostridium difficile in adults: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17314214" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Extreme leukocytosis in the emergency department.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2005777" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Adult Still's disease: manifestations, disease course, and outcome in 62 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9817152" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Systemic markers of inflammation in stable bronchiectasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8603558" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC)
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5635603" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : The effect of splenectomy on the leucocyte count.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5058244" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Persistent neutrophilic leukocytosis associated with idiopathic functional asplenia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5811425" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Functional asplenia in sickle-cell anemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12871694" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8980369" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Smoking, alcohol consumption, and leukocyte counts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8055125" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Cigarette smoking and peripheral blood leukocyte differentials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15163468" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Smoking-induced leukocytosis can persist after cessation of smoking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12160596" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Quitting smoking may restore hematological characteristics within five years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16092581" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Effects of biochemically confirmed smoking cessation on white blood cell count.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32682870" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Leukocytosis and Tobacco Use: An Observational Study of Asymptomatic Leukocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6249848" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Diminished polymorphonuclear leukocyte adherence. Function dependent on release of cyclic AMP by endothelial cells after stimulation of beta-receptors by epinephrine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2954481" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Exercise-induced changes in the blood concentration of leukocyte populations in teenage athletes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/495565" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Pitfalls in the interpretation of leukocyte counts of newborn infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3804928" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Leukocytosis of exercise: role of cardiac output and catecholamines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3117270" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Leucocytosis induced by exercise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16696775" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19551882" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35384034" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Splenomegaly: Dare to think rare.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35490291" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Diagnosis and discovery: Insights from the NIH Undiagnosed Diseases Program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31697825" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Inherited transmission of the CSF3R T618I mutational hotspot in familial chronic neutrophilic leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29512199" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26980727" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/148990" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Congenital leukaemia and the neonatal myeloproliferative disorders associated with Down's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/265027" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Hypoglycemia and leukemoid reaction with hypernephroma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2954483" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Transient blastemia in phenotypically normal newborns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6444534" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Transient leukemoid reaction and trisomy 21 mosaicism in a phenotypically normal newborn.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6632146" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Spurious leukocytosis and thrombocytopenia. A dual phenomenon caused by clumping of platelets in vitro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6422738" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Pseudoleukocytosis due to EDTA-induced platelet clumping.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3818970" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Pseudoleucocytosis and pseudothrombocytosis due to cryoglobulinaemia.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
